stori
selfrepl
rna
start
recognit
infecti
natur
viral
rna
genom
evid
nake
rna
upon
introduct
cell
abl
promot
full
replic
cycl
includ
releas
infecti
viru
particl
repres
start
point
new
era
research
rna
viru
molecular
biolog
applic
due
technic
difficulti
rna
amen
site
specif
manipul
revers
genet
system
rna
virus
alway
reli
c
dna
intermedi
first
success
approach
toward
recoveri
replic
virus
clone
c
dna
publish
positivestrand
rna
virus
reli
transfect
plasmid
dna
contain
viru
deriv
c
dna
insert
soon
afterward
vitro
transcript
transfect
viral
genomelik
rna
describ
lead
recoveri
infecti
progeni
viru
positivestrand
rna
virus
first
rna
virus
amen
direct
genet
manipul
due
simpl
strategi
gene
express
replic
genom
rna
vrna
repres
mrna
abl
govern
product
viral
protein
necessari
initi
viru
replic
product
first
round
translat
viral
genom
rna
assembl
replicas
complex
polymer
minu
strand
complementari
genom
c
rna
templat
synthesi
addit
mrna
molecul
thu
posit
strand
rna
virus
compon
replicas
complex
translat
directli
genom
rna
viral
polypeptid
requir
rna
replic
mainli
constitut
structur
protein
either
also
translat
genom
rna
one
subgenom
mrna
transcrib
neg
sens
c
rna
templat
depend
specif
type
viru
genom
member
group
use
former
express
strategi
contain
one
long
open
read
frame
orf
translat
rna
lead
polyprotein
cotransl
posttransl
process
viral
host
cellular
proteas
member
famili
belong
first
group
fig
second
group
compris
famili
virus
character
subgenom
rna
use
express
part
gene
fig
contrast
first
group
replicas
gene
virus
locat
part
genom
upstream
structur
gene
virus
subgenom
rna
cotermin
genom
rna
possibl
recov
selfrepl
viral
rna
clone
c
dna
sequenc
open
window
sophist
studi
mechan
rna
viru
replic
moreov
knowledg
crucial
establish
ration
attenu
virus
well
develop
strategi
use
selfrepl
rna
express
foreign
gene
vaccin
purpos
applic
chapter
present
technic
principl
use
establish
selfrepl
rna
select
exampl
applic
context
vaccin
develop
due
greater
instabl
singl
strand
rna
versu
dna
wealth
techniqu
dna
manipul
contrast
difficulti
direct
rna
manipul
recombin
viru
system
base
dna
construct
even
case
rna
virus
system
reli
c
dna
viral
rna
due
infecti
natur
posit
strand
rna
viru
genom
revers
genet
system
posit
strand
rna
virus
need
much
complic
way
deliv
genomelik
rna
cell
success
replic
said
rna
viru
recoveri
histori
revers
genet
system
posit
strand
rna
virus
highlight
pitfal
may
encount
design
revers
genet
system
show
solut
circumv
difficulti
difficulti
coval
link
genom
structur
found
differ
posit
strand
rna
viru
famili
genom
cap
link
socal
vpgprotein
contain
nake
end
end
form
loop
structur
polya
tail
would
expect
mrna
depend
viru
correct
end
import
crucial
replic
andor
translat
product
subgenom
rna
fig
first
infecti
c
dna
clone
eukaryot
viru
c
dna
clone
polioviru
construct
complet
c
dnasequ
includ
residu
poli
tail
plasmid
yield
infecti
viru
particl
upon
transfect
mammalian
cell
first
construct
contain
dedic
promot
ensur
transcript
viral
rna
nevertheless
led
enough
rna
express
viru
recoveri
three
year
later
perform
polioviru
c
dna
clone
could
significantli
amelior
introduct
transcript
replic
signal
transfect
result
construct
cell
express
larg
antigen
thu
ensur
replic
dnaplasmid
eukaryot
cell
lead
higher
yield
viral
rna
recov
viru
fig
left
part
picornavirus
clone
c
dna
bacteri
plasmid
enough
establish
construct
lead
product
infecti
viru
progeni
inde
first
c
dna
clone
rhinoviru
type
fail
produc
infecti
viral
particl
addit
bacteriophag
promot
upstream
c
dna
combin
vitro
transcript
c
dna
produc
rna
led
infecti
progeni
upon
transfect
cell
fig
middl
equival
approach
also
use
revers
genet
system
brome
mosaic
viru
consist
three
plasmid
contain
c
dna
three
viral
genom
rna
immedi
downstream
promot
drive
vitro
transcript
combin
transfect
three
vitro
transcrib
rna
led
viru
infect
plant
anoth
problem
encount
gener
revers
genet
system
fact
plasmid
contain
viral
c
dna
unstabl
andor
induc
cytotox
mani
case
cytotox
instabl
viral
c
dna
could
counter
success
use
low
copi
plasmid
exampl
origin
replic
restrict
plasmid
copi
number
per
cell
approach
success
first
infecti
clone
pestivirus
ncpbvdv
cpbvdv
csfv
fail
case
yellow
fever
viru
yfv
problem
led
develop
strategi
use
two
plasmid
contain
differ
part
virusderiv
c
dna
first
yfv
infecti
c
dna
clone
vaccin
strain
first
flaviviru
infecti
clone
consist
two
separ
fragment
correspond
half
genom
respect
infecti
rna
gener
vitro
ligat
two
fragment
follow
vitro
transcript
fig
right
part
correct
end
end
viral
genom
often
import
success
revers
genet
system
mani
virus
reli
special
structur
termini
replic
andor
translat
system
describ
use
restrict
enzym
site
introduc
directli
downstream
viral
c
dna
linear
plasmid
runoff
vitro
transcript
obtain
rna
end
ident
similar
possibl
viral
genom
regard
end
rna
use
bacteriophag
promot
mostli
allow
transcrib
rna
margin
modifi
even
desir
start
sinc
g
residu
necessari
effici
transcript
enzym
infecti
c
dna
clone
member
establish
promot
directli
upstream
genom
c
dna
blunt
cut
restrict
enzym
recognit
site
directli
overlap
end
genom
allow
runoff
vitro
transcript
result
rna
ident
viral
genom
rna
altern
vitro
ligat
c
dna
fragment
interest
approach
base
reconstitut
full
length
viral
genom
rna
via
intracellular
rna
recombin
develop
rna
recombin
natur
occur
process
widespread
rna
virus
give
rise
new
viru
variant
cytopath
biotyp
pestivirus
recombin
rna
posit
strand
rna
virus
replic
cytoplasm
infect
cell
differ
dna
recombin
cellular
rna
splice
dedic
cellular
machineri
join
end
respect
nucleic
acid
recombin
cytoplasm
rna
thought
occur
either
templat
switch
rnadepend
polymeras
genom
replic
breakag
rna
join
rna
end
sever
experi
pestiviru
polioviru
mutant
shown
rna
recombin
happen
independ
activ
rna
replic
experi
rna
fragment
encod
part
rnadepend
rna
polymeras
cotransfect
cell
suffici
lead
recoveri
infecti
viru
fact
intracellular
recombin
viral
rna
occur
rather
frequent
use
tool
manipul
viral
genom
yet
access
revers
genet
system
c
dna
clone
similar
approach
via
recombin
mutat
genom
fragment
mention
instabl
viral
full
length
c
dna
clone
part
depend
size
viral
genom
first
c
dna
clone
establish
member
genom
size
kb
member
genom
size
kb
coronavirus
largest
rna
genom
therefor
remain
inaccess
revers
genet
system
base
c
dna
clone
long
time
instead
target
mutagenesi
achiev
recombin
transfect
vitro
transcrib
rna
repres
part
viral
genom
full
length
viral
rna
infect
cell
took
year
first
infecti
full
length
c
dna
clone
picornaviru
full
length
infecti
c
dna
clone
member
latter
construct
transmiss
gastroenter
viru
tgev
use
bacteri
artifici
chromosom
bac
propag
larg
viru
deriv
c
dna
low
copi
number
part
genom
toxic
bacteria
furthermor
c
dna
clone
contain
tgev
sequenc
downstream
cytomegaloviru
immedi
earli
promot
upon
transfect
dna
cell
viral
rna
produc
cellular
rna
polymeras
ii
led
product
infecti
viral
particl
year
second
c
dna
system
tgev
publish
use
five
separ
plasmid
togeth
contain
full
length
genom
need
assembl
vitro
ligat
rna
synthesi
yet
anoth
approach
follow
year
later
avian
coronaviru
infecti
bronchiti
viru
genom
c
dna
insert
genom
vaccinia
viru
larg
dna
viru
famili
poxvirida
howev
also
strategi
base
use
rna
recombin
still
employ
establish
recombin
coronavirus
method
gener
long
viral
c
dna
chang
last
year
first
approach
base
c
dna
librari
made
purifi
virion
rna
rna
infect
cell
later
full
length
pcr
amplif
viral
genom
becam
feasibl
avail
proofread
polymeras
allow
gener
infecti
clone
singl
round
revers
transcript
follow
longrang
pcr
rapid
develop
nucleic
acid
synthesi
high
throughput
sequenc
possibl
gener
c
dna
clone
synthesi
correspond
dna
sequenc
simpli
knowledg
sequenc
first
demonstr
polioviru
recent
c
dna
clone
system
base
synthet
plasmid
publish
coronaviru
porcin
epidem
diarrhea
viru
develop
strategi
establish
revers
genet
system
new
viru
allow
gener
selfrepl
rna
recoveri
recombin
viru
requir
knowledg
molecular
biolog
viru
varieti
consider
regard
final
aim
approach
first
step
usual
determin
sequenc
viral
genom
includ
correct
end
latter
inform
obtain
socal
race
technolog
rapid
amplif
c
dna
end
pcr
base
system
nowaday
provid
differ
commerci
supplier
knowledg
sequenc
provid
necessari
inform
genom
organ
help
understand
gene
express
strategi
viru
import
question
context
concern
mechan
promot
initi
translat
replic
viral
genom
rna
describ
translat
genom
necessari
provid
compon
replicas
start
genom
replic
therebi
initi
viral
life
cycl
posit
strand
rna
virus
develop
varieti
strategi
ensur
initi
translat
rna
system
infecti
c
dna
construct
design
way
cisact
structur
import
translat
replic
genomelik
rna
deriv
construct
equival
found
viral
genom
howev
special
case
provid
problem
calicivirus
protein
call
vpg
coval
bound
end
viral
rna
function
substitut
cap
structur
drive
translat
initi
eukaryot
mrna
protein
like
also
crucial
rna
accept
substrat
rna
replic
easili
link
vitro
transcrib
viral
rna
replac
vpg
standard
cap
structur
found
suffici
translat
initi
replic
vitro
transcrib
rna
quit
low
effici
similarli
end
viral
rna
import
success
recoveri
selfrepl
rna
mani
virus
contain
poli
tail
end
therebi
mimic
structur
standard
eukaryot
mrna
ensur
effici
translat
poli
tail
also
import
replic
viral
rna
sinc
sequenc
transcript
start
minu
strand
synthesi
viral
genom
contain
poli
exampl
specif
secondari
structur
repres
import
cisact
element
translat
rna
replic
gener
rule
viru
genom
contain
poli
tail
also
sequenc
infecti
c
dna
construct
wherea
virus
without
poli
tail
expect
sensit
chang
sequenc
genom
end
step
undertaken
ensur
gener
correct
genom
end
transcript
necessari
inform
viral
genom
strategi
gene
express
avail
next
point
decid
transcript
c
dna
construct
occur
major
revers
genet
system
posit
strand
rna
virus
genomelik
rna
gener
vitro
subsequ
introduc
cell
via
transfect
strategi
character
method
advantag
especi
simpl
gener
correct
end
sequenc
use
bacteriophag
rna
polymeras
runoff
transcript
transcript
procedur
improv
year
highli
effici
kit
yield
larg
amount
rna
becam
commerci
avail
common
promot
use
vitro
transcript
system
phage
promot
place
immedi
upstream
c
dna
sequenc
ensur
correct
end
result
rna
obtain
cap
transcript
either
cap
analog
like
ppp
g
includ
vitro
transcript
reaction
rna
need
cap
vitro
transcript
use
vaccinia
viru
deriv
cap
system
genom
rna
contain
polya
tail
need
either
includ
templat
construct
ad
transcript
use
poli
polymeras
second
choic
add
yet
anoth
step
gener
rna
thu
might
reduc
yield
mention
way
introduct
cap
structur
vitrotranscrib
rna
work
rather
low
effici
thu
altern
strategi
reli
transfect
plasmid
dna
follow
vivo
transcript
genomelik
rna
advantag
product
cap
transcript
necessari
sinc
rna
produc
transfect
cell
cap
polyadenyl
cellular
enzym
problem
approach
rel
high
chanc
posttranscript
modif
rna
like
splice
could
abrog
infect
obtain
correct
genom
end
nonpolyadenyl
virus
approach
ribozym
sequenc
hepat
delta
ribozym
ad
end
cleav
leav
correct
terminu
fact
revers
genet
system
posit
strand
rna
virus
use
direct
transfect
dna
cell
much
rarer
vitro
transcript
base
approach
interest
altern
combin
featur
vitro
transcript
system
advantag
dna
transfect
base
helper
virus
like
vaccinia
viru
mva
cell
infect
latter
viru
contain
bacteriophag
rna
polymeras
express
mva
upon
introduct
plasmid
construct
promot
transcrib
desir
rna
cytoplasm
cell
avoid
nuclear
locat
danger
unwant
splice
rna
product
defin
start
site
base
transcript
allow
easi
product
correct
end
vitro
transcript
insert
ribozym
sequenc
plasmid
ensur
format
desir
defin
end
transcript
sinc
vaccinia
viru
replic
cytoplasm
express
enzym
cap
polyadenyl
transcript
effici
also
true
transcript
final
result
effici
product
cap
polyadenyl
transcript
correct
end
within
cell
lead
superior
perform
compar
vitro
transcript
transfect
rna
mention
instabl
viral
sequenc
e
coli
propag
c
dna
plasmid
counter
differ
measur
prefer
use
low
copi
plasmid
bac
minim
amount
plasmid
toxic
sequenc
bacteria
moreov
bac
carri
larg
insert
thu
suitabl
everi
posit
strand
rna
viru
genom
includ
coronavirus
sequenc
seem
deleteri
propag
e
coli
disrupt
strateg
place
intron
sequenc
viru
recoveri
achiev
via
plasmid
transfect
cell
intracellular
rna
synthesi
rna
polymeras
ii
intron
splice
produc
rna
regener
viral
sequenc
within
cell
approach
employ
product
tgev
infecti
clone
taken
togeth
establish
system
gener
selfrepl
rna
recoveri
infecti
recombin
posit
strand
rna
virus
principl
straight
forward
today
pay
attent
individu
featur
respect
system
aim
achiev
depend
system
rare
use
strategi
like
rna
recombin
base
gener
mutant
might
show
feasibl
solut
fact
system
specif
problem
solv
develop
almost
revers
genet
system
routin
use
avail
repertoir
possibl
solut
problem
facilit
approach
futur
pestivirus
repres
good
exampl
differ
approach
toward
live
attenu
viral
vaccin
member
genu
econom
import
pathogen
farm
anim
group
famili
togeth
closest
rel
hepacivirus
import
pestivirus
classic
swine
fever
viru
csfv
bovin
viral
diarrhea
viru
bvdv
member
flavivirida
envelop
virus
posit
strand
rna
genom
contain
one
long
open
read
frame
econom
impact
pestivirus
result
least
part
caus
wide
rang
pregnanc
disord
persist
infect
due
abil
cross
placenta
pregnant
anim
persist
infect
anim
repres
import
reservoir
viru
spread
vaccin
repres
feasibl
mean
interrupt
cycl
transmiss
long
vaccin
prevent
diseas
also
fetal
transmiss
pathogen
fulfil
latter
demand
pestiviru
vaccin
potent
socal
csfv
cstrain
repres
exampl
success
pestiviru
vaccin
tradit
modifi
live
vaccin
attenu
via
serial
passag
rabbit
cell
result
safe
effici
vaccin
viru
far
undefin
basi
attenu
latter
also
true
differ
live
bvdv
strain
use
vaccin
variou
countri
worldwid
import
disadvantag
vaccin
attenu
virus
still
cross
placenta
infect
fetu
pregnant
anim
case
convent
live
bvdv
vaccin
even
lead
abort
use
revers
genet
approach
abl
establish
bvdv
mutant
defin
genom
delet
nonessenti
sequenc
knock
two
viral
factor
interf
host
type
interferon
respons
without
significantli
impair
viral
replic
consequ
chang
affect
viral
mechan
block
innat
immun
respons
bvdv
infect
complet
attenu
mutant
viru
observ
also
inabl
infect
fetu
pregnant
anim
prerequisit
pregnanc
disord
persist
infect
anoth
approach
base
delet
nonessenti
sequenc
describ
coronavirus
member
famili
repres
import
pathogen
man
anim
among
sar
mer
coronaviru
sarscov
merscov
best
known
outlin
coronavirus
far
largest
known
rna
genom
encod
essenti
also
nonessenti
accessori
protein
delet
five
eight
groupspecif
orf
either
alon
variou
combin
sarscov
genom
rna
result
clear
indic
attenu
mous
model
contrast
viabl
sarscov
mutant
lack
sequenc
code
e
protein
recov
exhibit
reduc
virul
two
anim
model
probabl
enhanc
respons
immun
respons
infect
e
repres
one
membran
bound
structur
protein
viru
involv
virion
assembl
releas
delet
mutant
still
character
improv
might
provid
basi
develop
coronaviru
vaccin
futur
delet
sequenc
also
exchang
genom
fragment
relat
virus
easili
done
via
revers
genet
lead
attenu
desir
featur
exampl
chimer
pestiviru
establish
vaccin
classic
swine
fever
fig
concept
base
replac
region
code
major
envelop
protein
bvdv
genom
correspond
sequenc
csfv
result
viru
abl
infect
pig
thu
display
tropism
csfv
chimer
viru
fulli
attenu
nevertheless
induc
strong
protect
immun
import
advantag
configur
chimera
allow
serolog
differenti
vaccin
anim
infect
csfv
field
viru
featur
major
import
control
erad
program
veterinari
medicin
similar
approach
also
use
member
genu
famili
first
approach
employ
yellow
fever
viru
yfv
vaccin
strain
viru
develop
empir
passag
yfv
effect
safe
vaccin
found
highli
trigger
innat
immun
respons
help
drive
adapt
immun
respons
long
last
protect
immun
therefor
yfv
chosen
backbon
chimer
japanes
encephalitisyellow
fever
viru
vaccin
surfac
protein
prme
code
region
yfv
replac
correspond
modifi
jev
sequenc
result
safe
effect
vaccin
launch
end
trade
name
similar
construct
background
establish
prme
sequenc
west
nile
viru
four
dengu
viru
denv
genotyp
test
vaccin
candid
also
chimer
denv
compos
sequenc
two
differ
denv
genotyp
encompass
attenu
mutat
establish
test
well
chimera
denv
tickborn
enceph
viru
sequenc
chimer
approach
also
follow
vaccin
trial
alphavirus
anoth
group
posit
strand
rna
virus
belong
famili
low
virul
sindbi
viru
provid
backbon
approach
use
exchang
complet
structur
protein
code
region
sequenc
highli
virul
alphavirus
like
eastern
western
venezuelan
equin
enceph
viru
eee
wee
vee
chimer
process
led
signific
attenu
result
virus
found
highli
immunogen
review
see
ref
nevertheless
safeti
issu
major
concern
approach
sinc
biomark
attenu
sindbi
viru
known
small
anim
model
test
virul
case
adequ
evalu
attenu
human
research
need
fulli
evalu
vaccin
candid
stress
approach
describ
employ
selfrepl
rna
repres
either
full
length
viral
genom
rna
delet
nonessenti
sequenc
accordingli
construct
allow
recoveri
infecti
viru
particl
present
introduct
vitrotranscrib
recombin
rna
cell
via
transfect
start
autonom
replic
lead
releas
infecti
virus
amplif
tissu
cultur
serv
vaccin
upon
administr
immun
respons
trigger
vaccin
viru
mimic
step
field
viru
infect
without
induct
signific
symptom
use
fulli
replic
compet
recombin
virus
bear
certain
risk
revers
virul
depend
type
attenu
mutat
risk
signific
theoret
relev
virus
contain
one
delet
introduct
delet
rna
viru
genom
lead
recoveri
attenu
virus
special
case
case
result
rna
longer
abl
promot
gener
infecti
progeni
long
delet
concern
sequenc
respons
replic
rna
mutant
rna
behav
replicon
amplifi
autonom
introduc
cell
lead
translat
signific
amount
encod
protein
typic
replicon
approach
base
delet
sequenc
code
one
structur
compon
viru
fig
replicon
import
tool
research
rna
replic
exampl
pestivirus
hepacivirus
pestivirus
replicon
also
test
vaccin
approach
case
essenti
sequenc
delet
genom
vaccin
candid
need
complement
tran
stabli
transfect
cell
provid
miss
factor
infect
host
organ
viru
particl
secret
complement
cell
repres
deadend
sinc
infecti
viru
releas
noncompl
cell
thu
vaccin
cross
border
live
attenu
virus
kill
vaccin
exhibit
safeti
featur
least
close
kill
vaccin
big
advantag
kill
vaccin
abil
express
viral
protein
within
cell
lead
mhc
present
viral
peptid
activ
tcell
respons
addit
humor
respons
interest
exampl
develop
replicon
approach
found
flavivirus
socal
pseudoinfecti
vaccin
integr
delet
differ
length
capsid
protein
code
region
viral
genom
result
autonom
replic
rna
longer
abl
promot
gener
infecti
viru
particl
howev
cell
harbor
replicon
secret
larg
amount
immunogen
prme
particl
propag
replicon
stabli
transfect
cell
provid
miss
c
protein
tran
lead
viruslik
particl
abl
conduct
singl
round
infect
highli
effici
establish
cell
produc
prme
particl
approach
dna
base
vaccin
develop
reli
two
separ
plasmid
one
contain
c
dna
repres
capsiddelet
viral
genom
anoth
express
miss
capsid
protein
cell
taken
plasmid
translat
present
viral
sequenc
also
releas
infecti
viru
particl
infect
cell
lead
enhanc
stimulu
immun
system
chimer
approach
replicon
backbon
deriv
one
flaviviru
speci
prme
code
sequenc
anoth
speci
test
success
chimer
system
describ
repres
special
case
gener
approach
toward
vaccin
base
selfrepl
rna
contain
foreign
sequenc
similar
chimer
construct
mention
replac
viral
proteincod
sequenc
foreign
gene
use
express
desir
protein
immun
contrast
chimer
virus
structur
protein
exchang
close
relat
virus
construct
usual
yield
autonom
propag
infecti
virus
replicon
harbor
non
relat
sequenc
instead
origin
structur
protein
altern
foreign
sequenc
insert
viral
genom
addit
inform
without
loss
essenti
viral
function
fulli
replicationcompet
recombin
virus
produc
prerequisit
success
establish
selfrepl
rna
express
foreign
gene
develop
strategi
integr
express
latter
sequenc
without
disturb
autonom
replic
rna
due
fact
posit
strand
rna
virus
use
express
strategi
base
translat
polyprotein
subsequ
proteolyt
process
integr
foreign
sequenc
viral
open
read
frame
combin
specif
process
step
common
approach
avoid
fusion
signific
number
unwant
residu
protein
interest
place
foreign
sequenc
end
viral
orf
insert
foot
mouth
diseas
viru
fmdv
code
region
foreign
sequenc
viral
polyprotein
fig
fmdv
short
peptid
amino
acid
abl
induc
irregular
stop
restart
translat
fact
provok
interrupt
polyprotein
translat
carboxi
terminu
lead
releas
upstream
protein
fragment
cterminu
restart
translat
prolin
follow
polyprotein
viral
protein
follow
downstream
free
ad
residu
eleg
approach
avoid
fusion
unwant
residu
reli
establish
bicistron
rna
construct
foreign
sequenc
usual
also
place
end
orf
stop
codon
desir
end
translat
region
instead
protein
code
region
ensur
process
protein
intern
ribosom
entri
site
ire
integr
foreign
sequenc
viral
orf
fig
foreign
sequenc
express
use
strategi
initi
translat
viral
protein
wt
viru
translat
termin
stop
codon
end
ire
recruit
ribosom
start
site
end
viral
orf
therebi
promot
translat
protein
necessari
replic
recombin
rna
altern
arrang
publish
bvdv
ire
foreign
sequenc
place
ntr
fig
similarli
virus
like
alphavirus
use
subgenom
rna
express
structur
protein
adapt
express
foreign
sequenc
approach
reli
standard
genom
organ
express
strategi
virus
viral
rna
contain
promot
sequenc
recruit
viral
rna
polymeras
intern
site
minu
strand
rna
replic
intermedi
start
transcript
mrna
subgenom
length
replac
viral
structur
protein
code
sequenc
downstream
intern
promot
desir
foreign
sequenc
lead
replicon
transcrib
mrna
code
foreign
protein
fig
altern
subgenom
rna
promot
duplic
insert
togeth
desir
foreign
sequenc
addit
cistron
viral
genom
rna
therebi
preserv
abil
drive
gener
infecti
replic
compet
viru
particl
base
principl
varieti
vaccin
strategi
develop
matter
fact
basic
approach
use
selfrepl
rna
vaccin
employ
packag
rna
virion
viruslik
particl
reason
prefer
nake
stabil
rna
base
extraordinari
perform
viral
infect
machineri
result
highli
effici
deliveri
rna
cell
sinc
selfrepl
rna
deriv
viral
genom
exhibit
intrins
properti
specif
packag
viral
particl
use
strategi
easi
straight
forward
howev
mention
mani
viru
particl
display
quit
limit
stabil
approach
reli
stabil
rna
could
well
advantag
certain
situat
especi
cold
chain
transport
deliveri
provid
interest
opportun
futur
could
vaccin
formul
contain
rna
genom
fulli
replic
compet
attenu
viru
stabil
form
infecti
viru
gener
vaccine
upon
administr
approach
would
combin
superior
resist
stabil
rna
efficaci
modifi
live
viral
vaccin
